RxDoctor Payments Data

Courtney Walters, OD

Optometrist · Wilmington, NCNPI 1871245662

Payments from drug & device makers

$3,583in general payments, 2019–2025

Across 52 payments — averaging $68.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$3K
  • Bausch & Lomb Americas Inc.$269
  • Oyster Point Pharma, Inc.$141
  • Dompe US, Inc.$138
  • Sun Pharmaceutical Industries Inc.$137
  • AbbVie$100
  • plus $221 from 5 others

What the payments were for

  • Travel & lodging$2,06158%
  • Food & beverage$1,52342%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,583 in reported general payments places this provider in the 80th percentile of 1,326 optometrist providers in North Carolina.

See all optometrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$99,859
Medicare patients
345
Services billed
2,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine74$85,543
XiidraLifitegrast54$51,786
LumiganBimatoprost70$36,338
EysuvisLoteprednol Etabonate56$27,444
XdemvyLotilaner14$25,668
Restasis MultidoseCyclosporine38$25,173
RocklatanNetarsudil Mesylat/Latanoprost56$23,447
VyzultaLatanoprostene Bunod34$15,955
MieboPerfluorohexyloctane/Pf19$14,253
CombiganBrimonidine Tartrate/Timolol35$11,377
Alphagan PBrimonidine Tartrate21$7,158
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol51$6,492
Lotemax SmLoteprednol Etabonate25$6,191
Prednisolone Acetate103$4,844
SimbrinzaBrinzolamide/Brimonidine Tart12$3,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan, Restasis Multidose, Combigan, Alphagan P$100$165,589238 claims
Bausch & Lomb Americas Inc.Xiidra, Vyzulta, Miebo$269$81,994107 claims
AlconSimbrinza$2,578$3,06812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,326 optometrist providers in North Carolina.

Other optometrist in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →